Exciva
Last verified 2026-05-06. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $55.1Mattributed |
|---|---|
| Latest round | series-b, $55.1M, 2026-01-20attributed |
| Founded | 2016 |
| Headquarters | Heidelberg, DE |
| Industry | bio |
| Stage | series-b+ |
| Website | exciva.com |
Heidelberg-based Exciva, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, today
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-20 | series-b | $55.1M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $55.1M | attributed | eu-startups named as publisher. No document URL on file. |
| Total raised $55.1M | attributed | eu-startups named as publisher. No document URL on file. |
| Company existence | self-reported | exciva.com, read 2026-05-06 |
| Description | self-reported | exciva.com, read 2026-05-06 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.